Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.74 USD
+0.09 (1.04%)
Updated Sep 5, 2024 04:00 PM ET
Pre-Market: $8.71 -0.03 (-0.34%) 8:32 AM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.74 USD
+0.09 (1.04%)
Updated Sep 5, 2024 04:00 PM ET
Pre-Market: $8.71 -0.03 (-0.34%) 8:32 AM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Zacks News
Walgreens (WBA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Faster adoption of digital health and recent partnerships are expected to have contributed to Walgreens' (WBA) first-quarter performance.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $51.99, marking a -0.5% move from the previous day.
Walgreens Boots Alliance (WBA) Reports Next Week: What Awaits?
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News for Dec 30, 2021
by Zacks Equity Research
The S&P 500 and Dow closed at record highs on Wednesday as investors shed Omicron fears despite a surge in new cases and hospitalizations.
Dow, S&P Set Fresh All-Time Closing Highs
by Mark Vickery
Value plays look to have dried up during the past few sessions that account for the front end of the Santa Claus Rally.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $50.48 in the latest trading session, marking a +0.14% move from the prior day.
Rite Aid (RAD) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 183.33% and 0.83%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Moves -0.04%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $48.83 in the latest trading session, marking a -0.04% move from the prior day.
Walgreens (WBA), Village MD Plan to Expand Into San Antonio
by Zacks Equity Research
Walgreens (WBA) and VillageMD to improve access to overall care for patients with chronic conditions by opening nine new Village Medical at Walgreens primary care practices in San Antonio.
Walgreens Boots Alliance (WBA) Stock Moves -0.73%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $49.14, moving -0.73% from the previous trading session.
GameStop (GME) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
GameStop (GME) delivered earnings and revenue surprises of -531.82% and 0.49%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $48.23 in the latest trading session, marking a -0.14% move from the prior day.
Walgreens Boots (WBA) Faces Margin Pressure, Solvency Issue
by Zacks Equity Research
Of late, increased reimbursement pressure and generic drug cost inflation have been hampering Walgreens Boots' (WBA) margin significantly.
Walgreens (WBA) Buys Remaining Stake in German Wholesale Business
by Zacks Equity Research
Walgreens' (WBA) recent acquisition of the remaining ownership stake helps the company to further solidify its position as a leading pharmaceutical wholesaler in Germany.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $46.08 in the latest trading session, marking a +0.39% move from the prior day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $47.32, moving +0.72% from the previous trading session.
Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots
by Zacks Equity Research
Individuals aged 18 years or older are eligible to avail Pfizer, Moderna or Johnson & Johnson COVID-19 vaccine boosters from Walgreens' (WBA) stores.
Walgreens Boots Alliance (WBA) Stock Moves -0.65%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $49.22 in the latest trading session, marking a -0.65% move from the prior day.
Walgreens (WBA), VillageMD Plan to Expand Into Tampa, Florida
by Zacks Equity Research
Walgreens (WBA), VillageMD to open 20 new Village Medical at Walgreens primary care practices in the Tampa area to improve access to overall care for patients with chronic conditions.
Here's Why You Should Hold on to Walgreens Boots (WBA) for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA) given its better-than-expected fourth-quarter fiscal 2021 results and strategic alliances.
Walgreens (WBA) to Make Additional Investment in VillageMD
by Zacks Equity Research
Walgreens (WBA) announced a $5.2-billion investment in VillageMD to bolster its strategic position in delivering value-based primary care.
Ride the Latest Market Rally With These ETFs
by Sweta Jaiswal, FRM
The third-quarter earnings season has begun with a bang, spreading optimism among investors.
NextGen's (NXGN) Integrated Platform Gets Leveraged by Mednax
by Zacks Equity Research
Mednax utilizes NextGen's (NXGN) fully-integrated platform to enhance its efficacy in placing crucial information on patients' health and well-being at the physician's fingertips.
Stock Market News for Oct 15, 2021
by Zacks Equity Research
U.S. stocks ended sharply higher on Thursday after upbeat earnings and better-than expected economic data gave a boost to investors¿¿¿ confidence.
Walgreens (WBA) Hits 300M Milestone With Vitamin Angels
by Zacks Equity Research
Walgreens (WBA) and Vitamin Angels are looking to hit a new goal of reaching 500 million women and children by the end of August 2025.